BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38007441)

  • 1. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.
    Pan H; Liu B; Luo X; Shen X; Sun J; Zhang A
    Lipids Health Dis; 2023 Nov; 22(1):205. PubMed ID: 38007441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
    Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
    Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram for predicting the risk of nonalcoholic fatty liver disease in older adults in Qingdao, China: A cross-sectional study.
    Wang Z; Cui J; Li X; Gao R; Feng E; Luo G; Guo B; Wu H; Sun Y; Sun J
    Asia Pac J Clin Nutr; 2024 Mar; 33(1):83-93. PubMed ID: 38494690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease.
    Peng K; Wang S; Gao L; You H
    Medicine (Baltimore); 2021 Jul; 100(26):e26415. PubMed ID: 34190160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population.
    Pan X; Xie X; Peng H; Cai X; Li H; Hong Q; Wu Y; Lin X; Xu S; Peng XE
    Front Public Health; 2020; 8():220. PubMed ID: 32714888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.
    Zhu W; Shi P; Fu J; Liang A; Zheng T; Wu X; Yuan S
    Lipids Health Dis; 2022 Dec; 21(1):149. PubMed ID: 36585668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.
    Cai X; Zhu Q; Cao Y; Liu S; Wang M; Wu T; Hong J; Ahmat A; Aierken X; Li N
    Biomed Res Int; 2021; 2021():5527460. PubMed ID: 34095297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.
    Huang G; Jin Q; Mao Y
    J Med Internet Res; 2023 Sep; 25():e46891. PubMed ID: 37698911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study.
    Cai X; Aierken X; Ahmat A; Cao Y; Zhu Q; Wu T; Li N
    Biomed Res Int; 2020; 2020():8852198. PubMed ID: 33204721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study.
    Zhou Y; Chai X; Guo T; Pu Y; Zeng M; Zhong A; Yang G; Cai J
    Front Public Health; 2022; 10():895045. PubMed ID: 35812496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and evaluation of a risk-prediction model for hypertension in elderly patients with NAFLD from a health management perspective.
    Zhang A; Luo X; Pan H; Shen X; Liu B; Li D; Sun J
    Sci Rep; 2022 Sep; 12(1):15138. PubMed ID: 36071077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.
    Zheng K; Yin Y; Guo H; Ma L; Liu R; Zhao T; Wei Y; Zhao Z; Cheng W
    Front Endocrinol (Lausanne); 2024; 15():1340644. PubMed ID: 38405152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population.
    Hua X; Zhang H; Yang W; Liu G; Zhang S; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1176019. PubMed ID: 37334312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
    Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
    Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population.
    Li L; You W; Ren W
    Acta Diabetol; 2017 Oct; 54(10):905-911. PubMed ID: 28698957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.
    Abeysekera KWM; Orr JG; Gordon FH; Howe LD; Hamilton-Shield J; Heron J; Hickman M
    BMC Gastroenterol; 2022 Jun; 22(1):323. PubMed ID: 35773644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population.
    Wang J; Xu C; Xun Y; Lu Z; Shi J; Yu C; Li Y
    Sci Rep; 2015 Nov; 5():16494. PubMed ID: 26568423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.
    Huang X; Xu M; Chen Y; Peng K; Huang Y; Wang P; Ding L; Lin L; Xu Y; Chen Y; Lu J; Wang W; Bi Y; Ning G
    Medicine (Baltimore); 2015 Oct; 94(40):e1682. PubMed ID: 26448014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.